KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Goodwill (2016 - 2025)

Historic Goodwill for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $69.1 billion.

  • Pfizer's Goodwill rose 77.44% to $69.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $69.1 billion, marking a year-over-year increase of 77.44%. This contributed to the annual value of $68.5 billion for FY2024, which is 109.76% up from last year.
  • According to the latest figures from Q3 2025, Pfizer's Goodwill is $69.1 billion, which was up 77.44% from $69.0 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Goodwill registered a high of $69.3 billion during Q1 2024, and its lowest value of $49.2 billion during Q4 2021.
  • Its 5-year average for Goodwill is $58.1 billion, with a median of $51.5 billion in 2023.
  • As far as peak fluctuations go, Pfizer's Goodwill tumbled by 1738.34% in 2021, and later surged by 3462.0% in 2024.
  • Pfizer's Goodwill (Quarter) stood at $49.2 billion in 2021, then grew by 4.4% to $51.4 billion in 2022, then skyrocketed by 31.94% to $67.8 billion in 2023, then increased by 1.1% to $68.5 billion in 2024, then grew by 0.84% to $69.1 billion in 2025.
  • Its last three reported values are $69.1 billion in Q3 2025, $69.0 billion for Q2 2025, and $68.4 billion during Q1 2025.